title: Can recombinant thrombomodulin play a preventive role for veno-occlusive disease after haematopoietic stem cell transplantation?
authors.forename: S
authors.initials: S
authors.lastname: Nomura
authors.forename: R
authors.initials: R
authors.lastname: Ozasa
authors.forename: T
authors.initials: T
authors.lastname: Nakanishi
authors.forename: S
authors.initials: S
authors.lastname: Fujita
authors.forename: M
authors.initials: M
authors.lastname: Miyaji
authors.forename: S
authors.initials: S
authors.lastname: Mori
authors.forename: T
authors.initials: T
authors.lastname: Yokoi
authors.forename: T
authors.initials: T
authors.lastname: Ito
authors.forename: K
authors.initials: K
authors.lastname: Ishii
mesh_terms: D000015:Abnormalities, Multiple / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control; D015415:Biomarkers / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D006086:Graft vs Host Disease; D019337:Hematologic Neoplasms / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D007239:Infections; D011183:Postoperative Complications; D013577:Syndrome; D018180:Thrombomodulin / Q000008:administration & dosage*; D014652:Vascular Diseases
chemical_list: D015415:Biomarkers; D016207:Cytokines; C546931:THBD protein, human; D018180:Thrombomodulin